Wednesday, August 5, 2020

Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug

Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug In a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP in the strengths of 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg.

from Moneycontrol Business News https://ift.tt/31mOuo9
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...